Barclays
CRNC icon

Barclays’s Cerence CRNC Stock Holding History

Barclays’s Portfolio CRNC Stock Details CRNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.2K Sell
6,730
-4,615
-41% -$45.2K ﹤0.01% 4163
2026
Q1 		$71.6K Sell
11,345
-56,494
-83% -$509K ﹤0.01% 4174
2025
Q4 		$725K Buy
67,839
+10,846
+19% +$119K ﹤0.01% 3644
2025
Q3 		$710K Sell
56,993
-28,223
-33% -$289K ﹤0.01% 3587
2025
Q2 		$870K Buy
85,216
+29,375
+53% +$259K ﹤0.01% 3434
2025
Q1 		$441K Sell
55,841
-7,625
-12% -$93.8K ﹤0.01% 3609
2024
Q4 		$498K Buy
63,466
+6,596
+12% +$33.1K ﹤0.01% 3822
2024
Q3 		$179K Buy
56,870
+38,741
+214% +$114K ﹤0.01% 4356
2024
Q2 		$51.3K Sell
18,129
-31,168
-63% -$222K ﹤0.01% 4204
2024
Q1 		$776K Sell
49,297
-43,533
-47% -$736K ﹤0.01% 3309
2023
Q4 		$1.83M Buy
92,830
+67,715
+270% +$1.18M ﹤0.01% 2988
2023
Q3 		$512K Buy
25,115
+2,755
+12% +$69.3K ﹤0.01% 2797
2023
Q2 		$654K Sell
22,360
-391
-2% -$10.7K ﹤0.01% 2589
2023
Q1 		$639K Buy
22,751
+1,926
+9% +$49.4K ﹤0.01% 3090
2022
Q4 		$386K Buy
20,825
+7,694
+59% +$132K ﹤0.01% 3471
2022
Q3 		$207K Sell
13,131
-7,029
-35% -$158K ﹤0.01% 3182
2022
Q2 		$508K Sell
20,160
-18,306
-48% -$548K ﹤0.01% 2831
2022
Q1 		$1.39M Buy
+38,466
New +$1.89M ﹤0.01% 2160

Other funds holding CRNC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
ACM
American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $310M AUM 45.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Barclays's CRNC Position: Q2 2026 in Review

Barclays reduced its Cerence (CRNC) stake by 41% in Q2 2026, selling an estimated $45.2K and leaving 6,730 shares worth $76.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4163.

Barclays first reported a position in CRNC in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.83M in Q4 2023. 194 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

  • Barclays held 6,730 shares of Cerence worth $76.2K as of Q2 2026.
  • Barclays sold 4,615 Cerence shares in Q2 2026, an estimated $45.2K.
  • Cerence made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4163 holding.
  • Barclays first reported a position in Cerence in Q1 2022 and has held it in 18 quarters since.
  • Barclays's Cerence position peaked at $1.83M in Q4 2023.
  • 194 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.